Latest & greatest articles for nitroglycerin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on nitroglycerin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on nitroglycerin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for nitroglycerin

1. Subcutaneous Nitroglycerin for Radial Arterial Catheterization in Pediatric Patients: A Randomized Controlled Trial Full Text available with Trip Pro

Subcutaneous Nitroglycerin for Radial Arterial Catheterization in Pediatric Patients: A Randomized Controlled Trial Subcutaneous Nitroglycerin for Radial Arterial Catheterization in Pediatric Patients: A Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library (...) displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Anesthesiology Actions . 2020 Jul;133(1):53-63. doi: 10.1097/ALN.0000000000003308. Subcutaneous Nitroglycerin for Radial Arterial Catheterization in Pediatric Patients: A Randomized Controlled Trial , , , , , , Affiliations Expand Affiliation 1 From the Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Republic of Korea (Y.-E.J., S.-H.J., E.-H.K., J.-H.L.) the Department

2020 EvidenceUpdates

2. Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK Full Text available with Trip Pro

Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK Retained placenta following vaginal delivery is a major cause of postpartum haemorrhage. Currently, the only effective treatments for a retained placenta are the surgical procedures of manual removal of placenta (MROP) and uterine curettage, which are not universally available, particularly in low- and middle-income countries. The objective of the trial was to determine (...) whether sublingual nitroglycerin spray was clinically effective and cost-effective for medical treatment of retained placenta following vaginal delivery.A randomised, placebo-controlled, double-blind trial was undertaken between October 2014 and July 2017 at 29 delivery units in the UK (Edinburgh, Glasgow, Manchester, Newcastle, Preston, Warrington, Chesterfield, Crewe, Durham, West Middlesex, Aylesbury, Furness, Southampton, Bolton, Sunderland, Oxford, Nottingham [2 units], Burnley, Chertsey

2020 EvidenceUpdates

3. Glyceryl trinitrate to reduce the need for manual removal of retained placenta following vaginal delivery: the GOT-IT RCT Full Text available with Trip Pro

Glyceryl trinitrate to reduce the need for manual removal of retained placenta following vaginal delivery: the GOT-IT RCT Glyceryl trinitrate to reduce the need for manual removal of retained placenta following vaginal delivery: the GOT-IT RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above (...) to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} Glyceryl trinitrate spray did not reduce the need for manual removal of retained placenta following vaginal delivery. {{author}} {{($index , , , , , , , , , , , , & . Fiona C Denison 1, * , Kathryn F Carruthers 1 , Jemma Hudson 2 , Gladys McPherson 2 , Graham Scotland 3 , Sheonagh Brook-Smith 4, † , Cynthia Clarkson 1 , Mathilde Peace 1 , Jane Brewin 5 , Gin Nie Chua

2020 NIHR HTA programme

4. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. Full Text available with Trip Pro

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. High blood pressure is common in acute stroke and is a predictor of poor outcome; however, large trials of lowering blood pressure have given variable results, and the management of high blood pressure in ultra-acute stroke remains unclear. We investigated whether transdermal glyceryl trinitrate (GTN; also known (...) as nitroglycerin), a nitric oxide donor, might improve outcome when administered very early after stroke onset.We did a multicentre, paramedic-delivered, ambulance-based, prospective, randomised, sham-controlled, blinded-endpoint, phase 3 trial in adults with presumed stroke within 4 h of onset, face-arm-speech-time score of 2 or 3, and systolic blood pressure 120 mm Hg or higher. Participants were randomly assigned (1:1) to receive transdermal GTN (5 mg once daily for 4 days; the GTN group) or a similar sham

2019 Lancet Controlled trial quality: predicted high

5. It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosis. Full Text available with Trip Pro

It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosis. There is concern that blood pressure (BP) lowering in acute stroke may compromise cerebral perfusion and worsen outcome in the presence of carotid stenosis. We assessed the effect of glyceryl trinitrate (GTN) in patients with carotid stenosis using data from the Efficacy of Nitric Oxide in Stroke (ENOS) Trial.ENOS randomised 4011 patients with acute stroke (...) and raised systolic BP (140-220 mm Hg) to transdermal GTN or no GTN within 48 hours of onset. Those on prestroke antihypertensives were also randomised to stop or continue their medication for 7 days. The primary outcome was the modified Rankin Scale (mRS) at day 90. Ipsilateral carotid stenosis was split: <30%; 30-<50%; 50-<70%; ≥70%. Data are ORs with 95% CIs adjusted for baseline prognostic factors.2023 (60.5%) ischaemic stroke participants had carotid imaging. As compared with <30%, ≥70% ipsilateral

2019 Stroke and vascular neurology Controlled trial quality: predicted high

6. Effect of topical glyceryl trinitrate cream on pain perception during intrauterine device insertion in multiparous women: A randomized double-blinded placebo-controlled study. (Abstract)

Effect of topical glyceryl trinitrate cream on pain perception during intrauterine device insertion in multiparous women: A randomized double-blinded placebo-controlled study. Intrauterine contraceptive device (IUD) insertion-related pain presents a push beyond the decline of women to use IUD for family planning. We aimed to investigate the analgesic effect of glyceryl trinitrate cream (GTN) in reducing pain during IUD insertion.We conducted a randomized double-blinded placebo-controlled study (...) (NCT02708251, clinicaltrials.gov) in a tertiary University hospital. Reproductive-aged women requesting Copper IUD for contraception were considered. Eligible women for IUD insertion were randomized (1:1) to glyceryl trinitrate cream (GTN arm) or Placebo. Three minutes before IUD insertion, 1 ml of GTN cream or placebo was applied to the cervical lip at the planned tenaculum site, followed by 1 ml placed in the cervical canal up to the level of the internal os using a Q-tip applicator. Our outcomes were

2019 Journal of gynecology obstetrics and human reproduction Controlled trial quality: predicted high

7. Nitroglycerin

; Angelica dahurica (Hoffm.) Benth. & Hook.f. ex Franch. & Sav., root. AIM OF THE STUDY: In the present study, we aimed to elucidate the pharmacodynamic (...) action of DL and its mechanism in an animal model of migraines induced by glyceryl trinitrate ( GTN ). MATERIALS AND METHODS: Sixty rats were randomly divided into six groups, including a normal control group, model control group, positive group (Sumatriptan 0.006gkg -1 ), and three DL groups (0.44, 1.31 and 3.93gkg -1 ). All rats were (...) intragastrically treated with the corresponding treatment for 7 consecutive days, and they were subcutaneously injected with GTN (10mgkg -1 ) 30min after the last 2016 13. Nitroglycerin and Nitric Oxide - A Rondo of Themes in Cardiovascular Therapeutics. Nitroglycerin and Nitric Oxide--A Rondo of Themes in Cardiovascular Therapeutics. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract

2018 Trip Latest and Greatest

8. Efficacy of egg yolk and nitroglycerin ointment as treatments for acute anal fissures: A randomized clinical trial study. Full Text available with Trip Pro

Efficacy of egg yolk and nitroglycerin ointment as treatments for acute anal fissures: A randomized clinical trial study. Acute anal fissure as a common disease in society has several etiologies and manifestations such as severe anal pain and bleeding. Nitroglycerin ointment 0.2% is the most common topical treatment used. The most common side effect of nitroglycerin is headache, which is annoying for patients and often leads to discontinuation of the drug.Comparison of egg yolk as a natural (...) substance with analgesic and anti-inflammatory properties and minimal side effects with nitroglycerin ointment in the treatment of acute anal fissure.This randomized clinical trial was carried out during a 10-day period in the Gastroenterology clinic of Ghaem Hospital, Mashhad, Iran (year 2015). 126 patients who filled the inclusion criteria were enrolled. The patients were randomly divided into two groups. Nitroglycerin ointment (0.2%) was applied by patients in the first group, twice daily for 10 days

2016 Electronic physician Controlled trial quality: uncertain

9. Randomized clinical trial of the use of glyceryl trinitrate patches to aid arteriovenous fistula maturation Full Text available with Trip Pro

Randomized clinical trial of the use of glyceryl trinitrate patches to aid arteriovenous fistula maturation Arteriovenous fistulas are critical for haemodialysis, but maturation rates remain poor. Experimental and anecdotal evidence has supported the use of transdermal glyceryl trinitrate (GTN) patches. The aim of this RCT was to determine whether use of a GTN patch aids arteriovenous fistula maturation.Patients referred for arteriovenous fistula formation were eligible. The GTN or placebo (...) patch was applied immediately after surgery and left in situ for 24 h. The primary outcome measure was the change in venous diameter at 6 weeks after fistula formation. The secondary outcome measure was clinical fistula patency at 6 weeks.Of 200 patients recruited (533 screened), 101 were randomized to the placebo group and 99 to the GTN group. Of these, 81 and 86 respectively completed surgery, and had follow-up data available at 6 weeks. Improvements in venous diameter were similar in the two

2016 EvidenceUpdates Controlled trial quality: predicted high

10. Notice of Retraction: Jamal SA, et al. Effect of Nitroglycerin Ointment on Bone Density and Strength in Postmenopausal Women: A Randomized Trial. JAMA. 2011;305(8):800-807. Full Text available with Trip Pro

Notice of Retraction: Jamal SA, et al. Effect of Nitroglycerin Ointment on Bone Density and Strength in Postmenopausal Women: A Randomized Trial. JAMA. 2011;305(8):800-807. 26719994 2016 02 04 2019 02 25 1538-3598 315 4 2016 Jan 26 JAMA JAMA Notice of Retraction: Jamal SA, et al. Effect of Nitroglycerin Ointment on Bone Density and Strength in Postmenopausal Women: A Randomized Trial. JAMA. 2011;305(8):800-807. 418-9 10.1001/jama.2015.18431 Eastell Richard R Metabolic Bone Centre, Northern

2016 JAMA Controlled trial quality: uncertain

11. Nitroglycerin and Nitric Oxide - A Rondo of Themes in Cardiovascular Therapeutics. Full Text available with Trip Pro

Nitroglycerin and Nitric Oxide - A Rondo of Themes in Cardiovascular Therapeutics. 26510043 2015 10 30 2018 12 02 1533-4406 373 18 2015 10 29 The New England journal of medicine N. Engl. J. Med. Nitroglycerin and Nitric Oxide--A Rondo of Themes in Cardiovascular Therapeutics. 1789 10.1056/NEJMc1510178 Michel Thomas T Loscalzo Joseph J eng Letter Comment United States N Engl J Med 0255562 0028-4793 0 Vasodilator Agents 31C4KY9ESH Nitric Oxide G59M7S0WS3 Nitroglycerin AIM IM N Engl J Med. 2015 (...) Jul 16;373(3):277-80 26176386 N Engl J Med. 2015 Oct 29;373(18):1788-9 26510044 Humans Nitric Oxide history Nitroglycerin history Vasodilator Agents history 2015 10 29 6 0 2015 10 29 6 0 2015 10 31 6 0 ppublish 26510043 10.1056/NEJMc1510178 10.1056/NEJMc1510178#SA2

2015 NEJM

12. Nitroglycerin and Nitric Oxide - A Rondo of Themes in Cardiovascular Therapeutics. Full Text available with Trip Pro

Nitroglycerin and Nitric Oxide - A Rondo of Themes in Cardiovascular Therapeutics. 26510044 2015 10 30 2018 12 02 1533-4406 373 18 2015 10 29 The New England journal of medicine N. Engl. J. Med. Nitroglycerin and Nitric Oxide--A Rondo of Themes in Cardiovascular Therapeutics. 1788-9 10.1056/NEJMc1510178 Sauri Michael A MA eng Letter Comment United States N Engl J Med 0255562 0028-4793 0 Vasodilator Agents 31C4KY9ESH Nitric Oxide G59M7S0WS3 Nitroglycerin AIM IM N Engl J Med. 2015 Jul 16;373(3 (...) ):277-80 26176386 N Engl J Med. 2015 Oct 29;373(18):1789 26510043 Humans Nitric Oxide history Nitroglycerin history Vasodilator Agents history 2015 10 29 6 0 2015 10 29 6 0 2015 10 31 6 0 ppublish 26510044 10.1056/NEJMc1510178 10.1056/NEJMc1510178#SA1

2015 NEJM

13. Topical Nitroglycerin for Peripheral Circulation and Wound Healing in the Elderly

action on thrombophlebitis induced by sclerosis of leg varicose veins. Angiology. 1994 May;45(5):347-51. PubMed: PM8172381 6. Fischer M, Reinhold B, Falck H, Torok M, Alexander K. Topical nitroglycerin ointment in Raynaud's phenomenon. Z Kardiol. 1985 May;74(5):298-302. PubMed: PM3925656 7. Franks AG, Jr. Topical glyceryl trinitrate as adjunctive treatment in Raynaud's disease. Lancet. 1982 Jan 9;1(8263):76-7. PubMed: PM6119495 Non-Randomized Studies Unclear Population Age 8. Anderson ME, Moore TL (...) , Hollis S, Jayson MI, King TA, Herrick AL. Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis. Rheumatology (Oxford). 2002 Mar;41(3):324-8. PubMed: PM11934971 Topical Nitroglycerin for Peripheral Circulation and Wound Healing in the Elderly 5 9. Fletcher S, Wright M, Wilkinson A, Farr M, Sellars L. Locally applied transdermal nitrate patches for the treatment of ischaemic rest pain. Int J Clin Pract

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

14. Nitroglycerin for the treatment of pulmonary edema following submersion: clinical effectiveness and guidelines

Nitroglycerin for the treatment of pulmonary edema following submersion: clinical effectiveness and guidelines Nitroglycerin for the treatment of pulmonary edema following submersion: clinical effectiveness and guidelines Nitroglycerin for the treatment of pulmonary edema following submersion: clinical effectiveness and guidelines CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality (...) of this assessment has been made for the HTA database. Citation CADTH. Nitroglycerin for the treatment of pulmonary edema following submersion: clinical effectiveness and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary of Abstracts. 2014 Authors' conclusions No relevant health technology assessments, systematic reviews, meta-analyses, randomized controlled trials, non-randomized studies, or evidence-based guidelines were identified regarding the use

2014 Health Technology Assessment (HTA) Database.

15. Clevidipine compared with nitroglycerin for blood pressure control in coronary artery bypass grafting: a randomized double-blind study (Abstract)

Clevidipine compared with nitroglycerin for blood pressure control in coronary artery bypass grafting: a randomized double-blind study We tested the hypothesis that clevidipine, a rapidly acting dihydropyridine calcium channel blocker, is not inferior to nitroglycerin (NTG) in controlling blood pressure before cardiopulmonary bypass (CPB) during coronary artery bypass grafting (CABG).In this double-blind study from October 4, 2003 to April 26, 2004, 100 patients undergoing CABG with CPB were

2014 EvidenceUpdates Controlled trial quality: predicted high

16. Nitroglycerin for the Treatment of Pulmonary Edema Following Submersion

: Additional References 1. Gempp E, Louge P, Henckes A, Demaistre S, Heno P, Blatteau J-E. Reversible Myocardial Dysfunction and Clinical Outcome in Scuba Divers With Immersion Pulmonary Edema. The American Journal of Cardiology [Internet]. 2013 June [cited 2014 Mar 6]; 111(11): 1655–1659. Abstract available from: http://www.sciencedirect.com/science/article/pii/S0002914913005419 2. Best evidence topic reports. Bet 1. Managing acute pulmonary oedema: high or standard dose glyceryl trinitrate? Emerg Med J (...) Nitroglycerin for the Treatment of Pulmonary Edema Following Submersion TITLE: Nitroglycerin for the Treatment of Pulmonary Edema Following Submersion: Clinical Effectiveness and Guidelines DATE: 11 March 2014 RESEARCH QUESTIONS 1. What is the clinical effectiveness of nitroglycerin for the treatment of pulmonary edema secondary to submersion, in pre- or in-hospital settings? 2. What are the evidence-based guidelines regarding the use of nitroglycerin for the treatment of pulmonary edema

2014 Canadian Agency for Drugs and Technologies in Health - Rapid Review

17. Chronic anal fissure: 0.2% topical glyceryl trinitrate ointment

. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 25 of 291. (Rectiv or Rectogesic or Glyceryl trinitrate or glyceryltrinitrate).tw. (2144) 2. (T opical adj3 nitroglycerin).tw. (144) 3. (topical adj3 nitric oxide).tw. (37) 4. glyceryl trinitrate/ (23129) 5. 1 or 2 or 3 or 4 (23459) 6. Fissure in Ano/ (1971) 7. (anal adj3 fissure?).tw. (1407) 8. (ano adj3 fissure?).tw. (121) 9. 6 or 7 or 8 (2145) 10. 5 and 9 (467) 11. limit 10 to english language (401 (...) Chronic anal fissure: 0.2% topical glyceryl trinitrate ointment Chronic anal fissure: 0.2% topical gly Chronic anal fissure: 0.2% topical glyceryl ceryl trinitr trinitrate ointment ate ointment Evidence summary Published: 26 March 2013 nice.org.uk/guidance/esuom7 pathways K Ke ey points from the e y points from the evidence vidence The content of this evidence summary was up-to-date in March 2013. See summaries of product characteristics (SPCs), British national formulary (BNF), BNF

2013 National Institute for Health and Clinical Excellence - Advice

18. Topical glyceryl trinitrate may be effective in rotator cuff disease

Topical glyceryl trinitrate may be effective in rotator cuff disease PEARLS Practical Evidence About Real Life Situations PEARLS are succinct summaries of Cochrane Systematic Reviews for primary care practitioners. They Topical glyceryl trinitrate may be effective in rotator cuff disease Clinical question How effective is topical glyceryl trinitrate (GTN) for rotator cuff disease? Bottom line Three small studies, 1 at moderate risk of bias and 2 at high risk of bias, assessed the effectiveness (...) disease because of the very low quality of the evidence. Improvement in people's physical function was not measured by any of the studies included in the review. Context Topical GTN has been used to treat chest pain for many years, and has been proposed as a promising treatment for muscle and tendon injuries. For treatment of soft tissue conditions, GTN is delivered topically, through the skin, using medicated patches. Cochrane Systematic Review Cumpston M et al. Topical glyceryl trinitrate

2011 Cochrane PEARLS

19. Rectiv (nitroglycerin) Oinment

Rectiv (nitroglycerin) Oinment Drug Approval Package: Rectiv (nitroglycerin) NDA #021359 Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - Rectiv (nitroglycerin) Oinment 0.4% Company: ProStrakan, Inc. Application No.: 021359 Approval Date: 06/21/2011 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) Date created

2011 FDA - Drug Approval Package

20. Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial. Full Text available with Trip Pro

Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial. Nitroglycerin stimulates bone formation and inhibits bone resorption, is inexpensive, and is widely available. Its effects on bone density, bone structure, and bone strength are unknown.To determine if nitroglycerin increases lumbar spine bone mineral density (BMD) and to evaluate changes in hip BMD, bone geometry, and density at the radius and tibia, and markers of bone turnover.A single (...) -center, double-blind, placebo-controlled randomized trial conducted in Toronto, Ontario, Canada, for 24 months starting in November 2005 and completed in March 2010, of 243 postmenopausal women with lumbar spine T scores of between 0 and -2.0 who completed a 1-week run-in period taking nitroglycerin ointment. Intervention Nitroglycerin ointment (15 mg/d) or placebo applied at bedtime for 24 months.Areal BMD at the lumbar spine, femoral neck, and total hip. Secondary outcomes included indices of bone

2011 JAMA Controlled trial quality: predicted high